MiR-203 over-expression promotes prostate cancer cell apoptosis and reduces ADM resistance.
Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):2784. doi: 10.26355/eurrev_202003_20637.
Eur Rev Med Pharmacol Sci. 2020.
PMID: 32271394